<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35098828</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1365-2060</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>54</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of medicine</Title>
          <ISOAbbreviation>Ann Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Applications of research evidence during processes to acquire approvals for syringe services program implementation in rural counties in Kentucky.</ArticleTitle>
        <Pagination>
          <StartPage>404</StartPage>
          <EndPage>412</EndPage>
          <MedlinePgn>404-412</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2022.2028001</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Despite decades of empirical research in the US and internationally documenting the benefits of implementing syringe services programs (SSPs), their implementation may be controversial in many jurisdictions. Better understanding how research evidence is applied during SSP implementation processes may enable the public health workforce to advocate for program scale up. This study explores applications of research evidence during processes to acquire approvals for SSP implementation in rural counties in Kentucky.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In-depth interviews were conducted among eighteen stakeholders (e.g. health department directors, SSP operators) involved in SSP implementation in rural Kentucky counties. Stakeholders were asked to describe the contexts surrounding SSP implementation processes. Interviews were transcribed and analysed for applications of research evidence. Research evidence-related quotes were subsequently categorised based on the typologies for applications of research evidence developed by Weiss <i>et al.</i> (instrumental, conceptual, and symbolic) and a fourth category for instances when research evidence was not used.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Instrumental applications of research evidence occurred at the intrapersonal and interpersonal levels to dispel concerns about SSPs and formed the basis for implementation support. SSP proponents used research evidence in a conceptual manner to address underlying attitudes and beliefs that were not evidence-based. Participants reported symbolic research evidence applications to justify pre-existing attitudes and beliefs about meeting the public health needs of people who inject drugs. Lastly, in some instances, research evidence was met with scepticism and an unwillingness to consider its merits.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Applications of research evidence during SSP implementation approval processes in rural Kentucky counties were heterogeneous in nature. Better understanding the diversity of ways in which research evidence may be employed during SSP implementation processes may support efforts to improve the public health of people who inject drugs.Key messagesApplications of research evidence during SSP implementation approval processes in rural Kentucky counties were heterogeneous in nature.Instrumental applications of research evidence occurred at the intrapersonal and interpersonal levels to dispel concerns about SSPs and formed the basis for implementation support.SSP proponents used research evidence in a conceptual manner to address underlying attitudes and beliefs that were not evidence-based.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Allen</LastName>
            <ForeName>Sean T</ForeName>
            <Initials>ST</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grieb</LastName>
            <ForeName>Suzanne M</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Child and Community Health Research, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Glick</LastName>
            <ForeName>Jennifer L</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>White</LastName>
            <ForeName>Rebecca Hamilton</ForeName>
            <Initials>RH</Initials>
            <Identifier Source="ORCID">0000-0001-7894-4114</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Puryear</LastName>
            <ForeName>Tyler</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Katherine C</ForeName>
            <Initials>KC</Initials>
            <Identifier Source="ORCID">0000-0003-2140-1690</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Weir</LastName>
            <ForeName>Brian W</ForeName>
            <Initials>BW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sherman</LastName>
            <ForeName>Susan G</ForeName>
            <Initials>SG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>K01 DA046234</GrantID>
            <Acronym>DA</Acronym>
            <Agency>NIDA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Ann Med</MedlineTA>
        <NlmUniqueID>8906388</NlmUniqueID>
        <ISSNLinking>0785-3890</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007629" MajorTopicYN="N" Type="Geographic">Kentucky</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018671" MajorTopicYN="N">Needle-Exchange Programs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012424" MajorTopicYN="N">Rural Population</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015819" MajorTopicYN="Y">Substance Abuse, Intravenous</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013594" MajorTopicYN="Y">Syringes</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Injection drug use</Keyword>
        <Keyword MajorTopicYN="Y">drug policy</Keyword>
        <Keyword MajorTopicYN="Y">research evidence</Keyword>
        <Keyword MajorTopicYN="Y">rural</Keyword>
        <Keyword MajorTopicYN="Y">syringe services programs</Keyword>
      </KeywordList>
      <CoiStatement>The authors have no competing interests to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>31</Day>
          <Hour>8</Hour>
          <Minute>42</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35098828</ArticleId>
        <ArticleId IdType="pmc">PMC8812801</ArticleId>
        <ArticleId IdType="doi">10.1080/07853890.2022.2028001</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Larney S, Leung J, Grebely J, et al. . 
Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence. Int J Drug Policy. 2020;77:102656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31951926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Degenhardt L, Peacock A, Colledge S, et al. . 
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12) :e1192–e1207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5683738</ArticleId>
            <ArticleId IdType="pubmed">29074409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rashti R, Alavian SM, Moradi Y, et al. . 
Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and Meta-analysis. Arch Virol. 2020;165(9) :1947–1958.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32617764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leung J, Peacock A, Colledge S, et al. . 
A global Meta-analysis of the prevalence of HIV, hepatitis C virus, and hepatitis B virus among people who inject Drugs-Do Gender-Based differences vary by Country-Level indicators?
J Infect Dis. 2019;220(1) :78–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6775227</ArticleId>
            <ArticleId IdType="pubmed">30726973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Broz D, Wejnert C, Pham HT, et al. ; National HIV Behavioral Surveillance System Study Group . HIV infection and risk, prevention, and testing behaviors among injecting drug users – national HIV behavioral surveillance system, 20 U.S. cities, 2009. MMWR Surveill Summ. 2014;63(6):1–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24990587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hagan H, Pouget ER, Williams IT, et al. . 
Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. J Infect Dis. 2010;201(3):378–385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20053137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>CDC. Syringe Services Programs (SSPs) . 2019 5-23-19 [cited 2020 9-21-20]. https://www.cdc.gov/ssp/index.html.</Citation>
        </Reference>
        <Reference>
          <Citation>Des Jarlais DC, Nugent A, Solberg A, et al. . 
Syringe service programs for persons who inject drugs in urban, suburban, and rural Areas - United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(48):1337–1341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26655918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruiz MS, O'Rourke A, Allen ST.. 
Impact evaluation of a policy intervention for HIV prevention in Washington, DC. AIDS Behav. 2016;20(1) :22–28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4715855</ArticleId>
            <ArticleId IdType="pubmed">26336945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruiz MS, Oʼrourke A, Allen ST, et al. . 
Using interrupted time series analysis to measure the impact of legalized syringe exchange on HIV diagnoses in baltimore and philadelphia. J Acquir Immune Defic Syndr. 2019;82(Suppl 2):S148–s154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6820712</ArticleId>
            <ArticleId IdType="pubmed">31658203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aspinall EJ, Nambiar D, Goldberg DJ, et al. . 
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and Meta-analysis. Int J Epidemiol. 2014;43(1) :235–248.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24374889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandes RM, Cary M, Duarte G, et al. . 
Effectiveness of needle and syringe programmes in people who inject drugs - An overview of systematic reviews. BMC Public Health. 2017;17(1):309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5387338</ArticleId>
            <ArticleId IdType="pubmed">28399843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hagan H, McGough JP, Thiede H, et al. . 
Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in seattle drug injectors. J Subst Abuse Treat. 2000;19(3):247–252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11027894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Platt L, Minozzi S, Reed J, et al. . 
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database Syst Rev. 2017;9(9):Cd012021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5621373</ArticleId>
            <ArticleId IdType="pubmed">28922449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bornstein KJ, Coye AE, St Onge JE, et al. . 
Hospital admissions among people who inject opioids following syringe services program implementation. Harm Reduct J. 2020;17(1):30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7216361</ArticleId>
            <ArticleId IdType="pubmed">32398059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Des Jarlais DC.
Harm reduction in the USA: the research perspective and an archive to david purchase. Harm Reduct J. 2017;14(1):51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5530540</ArticleId>
            <ArticleId IdType="pubmed">28747189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allen ST, Grieb SM, O'Rourke A, et al. . 
Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs. Harm Reduct J. 2019;16(1):33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6528286</ArticleId>
            <ArticleId IdType="pubmed">31109339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sherman SG, Purchase D.. 
Point defiance: a case study of the United States' first public needle exchange in tacoma, Washington. Int J Drug Policy. 2001;12(1):45–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11275503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allen ST, Ruiz MS, Jones J.. 
Quantifying syringe exchange program operational space in the District Of Columbia. AIDS Behav. 2016;20(12):2933–2940.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5108823</ArticleId>
            <ArticleId IdType="pubmed">27094786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allen ST, Ruiz MS, Jones J, et al. . 
Legal space for syringe exchange programs in hot spots of injection drug use-related crime. Harm Reduct J. 2016;13:16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4845437</ArticleId>
            <ArticleId IdType="pubmed">27112328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones CM.
Syringe services programs: an examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S. Int J Drug Policy. 2019;70:22–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31059965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weinmeyer R.
Needle exchange programs' status in US politics. AMA J Ethics. 2016;18(3) :252–257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27002996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rich JD, Adashi EY.. 
Ideological anachronism involving needle and syringe exchange programs: Lessons from the Indiana HIV outbreak. Jama. 2015;314(1):23–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4496270</ArticleId>
            <ArticleId IdType="pubmed">26000661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernández-Viña MH, Prood NE, Herpolsheimer A, et al. . 
State laws governing syringe services programs and participant syringe possession, 2014-2019. Public Health Rep. 2020;135(1_suppl):128S–137s.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7407055</ArticleId>
            <ArticleId IdType="pubmed">32735195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson W.
The New York needle trial: the politics of public health in the age of AIDS. Am J Public Health. 1991;81(11):1506–1517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1405677</ArticleId>
            <ArticleId IdType="pubmed">1951815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allen ST, Ruiz MS, O'Rourke A.. 
The evidence does not speak for itself: the role of research evidence in shaping policy change for the implementation of publicly funded syringe exchange programs in three US cities. Int J Drug Policy. 2015;26(7):688–695.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4468034</ArticleId>
            <ArticleId IdType="pubmed">25979789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weiss CH, Murphy-Graham E, Birkeland S.. 
An alternate route to policy influence:How evaluations affect D.A.R.E. American Journal of Evaluation. 2005;26(1):12–30.</Citation>
        </Reference>
        <Reference>
          <Citation>Weiss CH.
The many meanings of research utilization. Public Administration Review. 1979;39(5):426–431.</Citation>
        </Reference>
        <Reference>
          <Citation>Amara N, Ouimet M, Landry R.. 
New evidence on instrumental, conceptual, and symbolic utilization of university research in government agencies. Science Communication. 2004;26(1):75–106.</Citation>
        </Reference>
        <Reference>
          <Citation>Cousins JB, Leithwood KA.. 
Current empirical research on evaluation utilization. Review of Educational Research. 1986;56(3):331–364.</Citation>
        </Reference>
        <Reference>
          <Citation>Weiss JA, Weiss CH.. 
Social scientists and decision makers look at the usefulness of mental health research. Am Psychol. 1981;36(8):837–847.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7294491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leviton LC, Hughes EFX.. 
Research on the utilization of evaluations:a review and synthesis. Eval Rev. 1981;5(4):525–548.</Citation>
        </Reference>
        <Reference>
          <Citation>Keyes KM, Cerdá M, Brady JE, et al. . 
Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. Am J Public Health. 2014;104(2):e52–e59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3935688</ArticleId>
            <ArticleId IdType="pubmed">24328642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monnat SM, Rigg KK.. 
Examining Rural/Urban Differences in Prescription Opioid Misuse Among US Adolescents . J Rural Health. 2016;32(2):204–218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4779738</ArticleId>
            <ArticleId IdType="pubmed">26344571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rigg KK, Monnat SM, Chavez MN.. 
Opioid-related mortality in rural america: Geographic heterogeneity and intervention strategies. Int J Drug Policy. 2018;57:119–129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29754032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rigg KK, Monnat SM.. 
Urban vs. rural differences in prescription opioid misuse among adults in the United States: informing region specific drug policies and interventions. Int J Drug Policy. 2015;26(5):484–491.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4397122</ArticleId>
            <ArticleId IdType="pubmed">25458403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weiss AJ, et al. . 
Opioid-Related inpatient stays and emergency department visits by state, 2009–2014: Statistical brief #219, in healthcare cost and utilization project (HCUP) statistical briefs. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006.</Citation>
        </Reference>
        <Reference>
          <Citation>Van Handel MM, Rose CE, Hallisey EJ, et al. . 
County-Level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr. 2016;73(3):323–331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5479631</ArticleId>
            <ArticleId IdType="pubmed">27763996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kentucky Cabinet for Health and Family Services . Syringe Exchange Programs. 7-20-21]; 2017. https://chfs.ky.gov/agencies/dph/dehp/hab/Pages/kyseps.aspx</Citation>
        </Reference>
        <Reference>
          <Citation>Morse JM.
The significance of saturation. Qual Health Res. 1995;5(2):147–149.</Citation>
        </Reference>
        <Reference>
          <Citation>CFIR Research Team-Center for Clinical Management Research . Consolidated Framework for Implementation Research. 7-20-21]; 2022. https://cfirguide.org/</Citation>
        </Reference>
        <Reference>
          <Citation>Kingdon JW.
Agendas, alternatives, and public policies. Boston: Little, Brown; 1984.</Citation>
        </Reference>
        <Reference>
          <Citation>Kentucky Cabinet for Health and Family Services. Syringe Exchange Programs; 2017 .</Citation>
        </Reference>
        <Reference>
          <Citation>CDC . 2018 Drug Overdose Death Rates. 2020.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
